TELZIR

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, South Africa

Active ingredients

The drug TELZIR contains one active pharmaceutical ingredient (API):

1 Fosamprenavir UNII ID1GU2627N - FOSAMPRENAVIR CALCIUM

Fosamprenavir after oral administration, is rapidly and almost completely hydrolysed to amprenavir and inorganic phosphate prior to reaching the systemic circulation. Amprenavir binds to the active site of HIV-1 protease and thereby prevents the processing of viral gag and gag-pol polyprotein precursors, resulting in the formation of immature noninfectious viral particles. Read about Fosamprenavir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TELZIR Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AE07	Fosamprenavir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors
Discover more medicines within J05AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10337C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510610601112219, 510614060051805
Country: CA	Health Products and Food Branch	Identifier(s): 02261545, 02261553
Country: EE	Ravimiamet	Identifier(s): 1204782, 1204793
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 04282001, 04282002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 091016
Country: FR	Base de données publique des médicaments	Identifier(s): 61312477, 63544054
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 79636
Country: IT	Agenzia del Farmaco	Identifier(s): 036475010, 036475022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031081, 1031082
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 76007
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100092192, 100092772
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65021001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522096268
Country: ZA	Health Products Regulatory Authority	Identifier(s): A38/20.2.8/0378, A38/20.2.8/0379